Leonore (Ethinylestradiol, Levonorgestrel)

The ethinylestradiol component supplies estrogenic activity that stabilises the endometrium, while levonorgestrel acts as a progestogen. Together they suppress the mid‑cycle surge of luteinising hormone and follicle‑stimulating hormone, preventing ovulation, thickening cervical mucus and altering the uterine lining to reduce the chance of implantation.

The dosing regimen for Leonore is determined by the prescribing healthcare professional. Typically, it is taken as one tablet daily at the same time each day, but the exact schedule and any missed‑dose instructions are provided by the prescriber.

Leonore is contraindicated in pregnancy (Category X) and must not be started in women who are pregnant or suspect they might be. While limited data exist for breastfeeding, the progestogen component may affect milk production, so use is generally discouraged unless clearly indicated by a physician.

To order Leonore, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams across international markets, and will request verification of trade or institutional credentials. The team then replies with pricing, availability, shipping details and any necessary import documentation.

Leonore contains standard doses of ethinylestradiol and levonorgestrel, offering efficacy comparable to other combined oral contraceptives. Differences among products usually relate to hormone dose strength, pill regimen (21‑day vs 24‑day cycles), and specific formulation excipients, which may influence side‑effect profiles or tolerability for individual patients.

Leonore tablets should be stored at ambient temperature, preferably below 25 °C, in the original blister pack or container. Protect them from excess moisture, direct sunlight and heat. Do not store in bathrooms or near kitchen appliances that generate steam.

Leonore is taken orally as a tablet. The recommended practice is to swallow one tablet each day, preferably at the same time, with or without food. Consistent daily intake maintains hormone levels and maximises contraceptive effectiveness.

Serious risks include thromboembolic events such as deep‑vein thrombosis, pulmonary embolism, stroke and myocardial infarction. Women should seek immediate medical attention if they experience sudden leg pain, shortness of breath, chest pain, severe headache, or visual disturbances, as these may signal a life‑threatening complication.

Leonore should not be used by women with a history of thromboembolic disorders, uncontrolled hypertension, certain cardiovascular diseases, active liver disease, known or suspected pregnancy, or those who are smokers over the age of 35. It is also contraindicated in individuals with known hypersensitivity to any component of the tablet.